Océanie · Marchés régionaux · Stockhead

Orthocell partner receives US FDA clearance for marine-derived bone graft

Publié par Stockhead · Australie il y a 1 h

Perth-based Orthocell has finalised a strategic investment in Marine Biomedical in January 2026, increasing its equity interest to 12% for ... Read More The post Orthocell partner…

Lire l'article complet sur Stockhead Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (stockhead.com.au)

Orthocell partner receives US FDA clearance for marine-derived bone graft

À lire aussi

Canva doubles down with OpenAI just days after launching its 2nd in-house AI model

Breaking: RBA lifts interest rates to highest level in 18 years to try to dampen inflation

Interest rates at highest since GFC

Cash rate hits highest level in 18 years

Carry It Like Makybe

IFM Investors appoints global product strategy head

Orthocell partner receives US FDA clearance for marine-derived bone graft

Partager

À lire aussi

Canva doubles down with OpenAI just days after launching its 2nd in-house AI model

Breaking: RBA lifts interest rates to highest level in 18 years to try to dampen inflation

Interest rates at highest since GFC

Cash rate hits highest level in 18 years

Carry It Like Makybe

IFM Investors appoints global product strategy head